Virulence Factors and Antifungal Susceptibility in Candida Species Isolated from Dermatomycosis Patients

Overview

Journal Mycopathologia

Specialties Microbiology
Pharmacology

Date 2020 Nov 20

PMID 33216273

Citations 3

Authors

Victor Galvao Mello

Heloisa Escudeiro

Ana Carolina Villas Boas Weckwerth

Maria Izilda Andrade

Ana Elisa Fusaro

Eloise Brasil de Moraes

Luciana da Silva Ruiz

Ida Maria Foschiani Dias Baptista

Affiliations

Soon will be listed here.

Abstract

Dermatomycoses caused by Candida spp. are increasingly common, however there are few reports in the literature regarding their epidemiology, pathogenesis and antifungal susceptibility of these fungal pathogens. This study aimed to identify, characterize virulence and determine the antifungal susceptibility of Candida species isolated from patients with dermatomycoses. We studied a total of 45 yeast samples isolated from dermal scrapings from patients treated at a public hospital, Bauru, São Paulo, Brazil. After identification, the samples were analyzed for protease activity, phospholipase, biofilm formation and antifungal susceptibility. The most common species was Candida albicans (40%), followed by C. krusei (22.22%), C. parapsilosis complex (22.22%) and C. famata (6.67%). Regarding virulence mechanisms, 57.78% and 28.89% of the samples showed enzymatic activity for protease and phospholipase, respectively. A total of 13.33% of the samples showed secretion of both enzymes. All isolates were biofilm producers, and a higher production was observed in C. tropicalis isolates. Regarding the antifungal susceptibility test, 97.78% of the samples had the highest levels of the minimal inhibitory concentration (MIC) for terbinafine, and one C. krusei sample showed intermediate susceptibility to fluconazole. The correct identification of dermatomycosis-related microorganisms, as well as a better knowledge of their pathogenicity and susceptibility against the antifungals used in the clinic, is extremely important for an efficient preventive and therapeutic action.

Citing Articles

Phenotypic and Genotypic Characterization of Resistance and Virulence Markers in spp. Isolated from Community-Acquired Infections in Bucharest, and the Impact of AgNPs on the Highly Resistant Isolates.

Corbu V, Georgescu A, Marinas I, Pericleanu R, Mogos D, Dumbrava A J Fungi (Basel). 2024; 10(8).

PMID: 39194889 PMC: 11355189. DOI: 10.3390/jof10080563.

Correlation Between Drug Resistance and Virulence of Isolates from Patients with Candidiasis.

Yang Z, Zhang F, Li D, Wang S, Pang Z, Chen L Infect Drug Resist. 2022; 15:7459-7473.

PMID: 36544991 PMC: 9762413. DOI: 10.2147/IDR.S387675.

Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 14: suitability of taxonomic units notified to EFSA until March 2021.

Koutsoumanis K, Allende A, Alvarez-Ordonez A, Bolton D, Bover-Cid S, Chemaly M EFSA J. 2021; 19(7):e06689.

PMID: 34257732 PMC: 8262138. DOI: 10.2903/j.efsa.2021.6689.

References

Charles A . Superficial cutaneous fungal infections in tropical countries. Dermatol Ther. 2009; 22(6):550-9. DOI: 10.1111/j.1529-8019.2009.01276.x. View

Garber G . An overview of fungal infections. Drugs. 2001; 61 Suppl 1:1-12. DOI: 10.2165/00003495-200161001-00001. View

Rotta I, Otuki M, Sanches A, Correr C . Efficacy of topical antifungal drugs in different dermatomycoses: a systematic review with meta-analysis. Rev Assoc Med Bras (1992). 2012; 58(3):308-18. View

da Silva Pontes Z, de Oliveira Lima E, Oliveira N, Dos Santos J, Ramos A, Carvalho M . Onychomycosis in João Pessoa City, Brazil. Rev Argent Microbiol. 2002; 34(2):95-9. View

Heidrich D, Stopiglia C, Magagnin C, Daboit T, Vettorato G, Amaro T . SIXTEEN YEARS OF DERMATOMYCOSIS CAUSED BY Candida spp. IN THE METROPOLITAN AREA OF PORTO ALEGRE, SOUTHERN BRAZIL. Rev Inst Med Trop Sao Paulo. 2016; 58:14. PMC: 4804551. DOI: 10.1590/S1678-9946201658014. View

Jayatilake J, Tilakaratne W, Panagoda G . Candidal onychomycosis: a mini-review. Mycopathologia. 2009; 168(4):165-73. DOI: 10.1007/s11046-009-9212-x. View

da Silva C, da Silva D, Martins C, de Resende M, Dias E, Magalhaes T . Synthesis of aryl aldimines and their activity against fungi of clinical interest. Chem Biol Drug Des. 2011; 78(5):810-5. DOI: 10.1111/j.1747-0285.2011.01185.x. View

Sav H, Baris A, Turan D, Altinbas R, Sen S . The frequency, antifungal susceptibility and enzymatic profiles of Candida species in cases of onychomycosis infection. Microb Pathog. 2018; 116:257-262. DOI: 10.1016/j.micpath.2018.01.036. View

Carrillo-Munoz A, Tur-Tur C, Hernandez-Molina J, Santos P, Cardenes D, Giusiano G . [Antifungal agents for onychomycoses]. Rev Iberoam Micol. 2010; 27(2):49-56. DOI: 10.1016/j.riam.2010.01.007. View

10.

Ruchel R, Tegeler R, Trost M . A comparison of secretory proteinases from different strains of Candida albicans. Sabouraudia. 1982; 20(3):233-44. DOI: 10.1080/00362178285380341. View

11.

Price M, Wilkinson I, Gentry L . Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia. 1982; 20(1):7-14. DOI: 10.1080/00362178285380031. View

12.

Melo A, Bizerra F, Freymuller E, Arthington-Skaggs B, Colombo A . Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex. Med Mycol. 2010; 49(3):253-62. DOI: 10.3109/13693786.2010.530032. View

13.

Marcos-Zambrano L, Escribano P, Bouza E, Guinea J . Production of biofilm by Candida and non-Candida spp. isolates causing fungemia: comparison of biomass production and metabolic activity and development of cut-off points. Int J Med Microbiol. 2014; 304(8):1192-8. DOI: 10.1016/j.ijmm.2014.08.012. View

14.

Nguyen M, Clancy C, Yu V, Yu Y, Morris A, Snydman D . Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia. J Infect Dis. 1998; 177(2):425-30. DOI: 10.1086/514193. View

15.

Vasconcellos C, Pereira C, Souza M, Pelegrini A, Freitas R, Takahashi J . Identification of fungi species in the onychomycosis of institutionalized elderly. An Bras Dermatol. 2013; 88(3):377-80. PMC: 3754368. DOI: 10.1590/abd1806-4841.20131884. View

16.

Feng X, Ling B, Yang X, Liao W, Pan W, Yao Z . Molecular Identification of Candida Species Isolated from Onychomycosis in Shanghai, China. Mycopathologia. 2015; 180(5-6):365-71. DOI: 10.1007/s11046-015-9927-9. View

17.

Xiao M, Fan X, Chen S, Wang H, Sun Z, Liao K . Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance. J Antimicrob Chemother. 2014; 70(3):802-10. DOI: 10.1093/jac/dku460. View

18.

Mobin M, Szeszs M, Takahashi J, Martins M, de Hippolito D, Porto J . Antifungal Susceptibility of Species Isolated from Horticulturists with Onychomycosis in Piauí, Brazil. Iran J Public Health. 2019; 47(12):1816-1821. PMC: 6379607. View

19.

Ilkit M, Tanir F, Hazar S, Gumusay T, Akbab M . Epidemiology of tinea pedis and toenail tinea unguium in worshippers in the mosques in Adana, Turkey. J Dermatol. 2005; 32(9):698-704. DOI: 10.1111/j.1346-8138.2005.tb00828.x. View

20.

Martins E, Guerrer L, Cunha K, Soares M, de Almeida M . [Onychomycosis: clinical, epidemiological and mycological study in the municipality of São José do Rio Preto]. Rev Soc Bras Med Trop. 2007; 40(5):596-8. DOI: 10.1590/s0037-86822007000500022. View